Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Bill Haynes joins us with the title of Visiting Professor of Metabolic Medicine. Professor Haynes is currently also the site head and Vice President of the Novo Nordisk Research Centre in Oxford, and was previously the Head and Vice President for Diabetes Biosciences at AstraZeneca. He has also been the Director of Translational Medicine (Cardiovascular and Metabolic) at the Novartis Institutes for Biomedical Research, preceded by 18 years at the University of Iowa, where he finished as the Professor for Cardiovascular Medicine and Endocrinology. 

A warm welcome to Professor Haynes in his new Visiting Professor position. 

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

James Davies named as Lister Research Prize Fellow

James Davies has been named as one of eight researchers selected for the 2022 Fellowship scheme.

Understanding the interplay of dietary iron, anaemia and the immune system

Four related projects aim to unravel how the iron we eat shapes how the immune system develops and responds to vaccines.

Six new Associate Professor titles at RDM

Graham Collins, Betty Raman, Susie Shapiro, Christopher Toepfer, Stephen Twigg, and Adam Wilkinson have all been awarded Associate Professor titles

Two NHSBT research units launch at RDM

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford, with two of them led by RDM researchers.